Literature DB >> 6160322

Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.

C G Regårdh, G Johnsson, L Jordö, P Lungborg, B A Persson, O Rönn.   

Abstract

The pharmacokinetics of metoprolol and propranolol in 6 healthy volunteers were compared after an intravenous dose of 10 mg of each drug. The mean t1/2, beta was 3.6 hr for both drugs, but due to a larger volume of distribution, the total body clearance was significantly higher for metoprolol (1.20 liters/min) than for propranolol (0.81 liters/min). The individual pharmacokinetic data were used to calculate the doses required to increase the amount of each drug in the body to 10 and 20 mg at 90 and 180 min respectively after an initial intravenous dose of 5.0 mg. The effect on exercise heart rate was determined 30 min after each dose. After identical doses, the two drugs had similar beta-blocking effects in terms of reducing exercise-induced tachycardia. These effects increased with the dose administered. The plasma levels of propranolol were twice as high as those of metoprolol for identical degrees of beta-blockade. The slope of the regression line for the relationship between the beta-blocking effect and log plasma concentrations was the same for the two drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160322     DOI: 10.1097/00005344-198011000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.

Authors:  Viera Lukacova; Walter S Woltosz; Michael B Bolger
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

2.  Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs.

Authors:  Rachel H Rose; David B Turner; Sibylle Neuhoff; Masoud Jamei
Journal:  AAPS J       Date:  2017-05-19       Impact factor: 4.009

3.  Inter- and intra-subject variability of metoprolol kinetics after intravenous administration.

Authors:  J Richard; J M Cardot; J Godbillon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

4.  Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals.

Authors:  C G Regårdh; S Landahl; M Larsson; P Lundborg; B Steen; K J Hoffmann; P O Lagerström
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Clinical Pharmacokinetics of Metoprolol: A Systematic Review.

Authors:  Ammara Zamir; Iltaf Hussain; Anees Ur Rehman; Waseem Ashraf; Imran Imran; Hamid Saeed; Abdul Majeed; Faleh Alqahtani; Muhammad Fawad Rasool
Journal:  Clin Pharmacokinet       Date:  2022-06-28       Impact factor: 5.577

6.  Metoprolol in acute myocardial infarction. A pharmacokinetic and pharmacodynamic study.

Authors:  P H Held; C G Regårdh
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Influence of smoking and gender on the disposition kinetics of metoprolol.

Authors:  L J Schaaf; S C Campbell; M B Mayersohn; T Vagedes; D G Perrier
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 8.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

9.  Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients.

Authors:  Muhammad Nasir Kalam; Muhammad Fawad Rasool; Faleh Alqahtani; Imran Imran; Asim Ur Rehman; Naveed Ahmed
Journal:  Drug Des Devel Ther       Date:  2021-03-17       Impact factor: 4.162

10.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.